New developments in the biology of fibroblast growth factors
WIREs Mechanisms of Disease · 2022-07 · 14 (4)
DOI: 10.1002/wsbm.1549 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Mechanisms of Disease, online erschienen am 09.02.2022. Verfasst von David M Ornitz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Receptors, Fibroblast Growth Factor. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 1534 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
The fibroblast growth factor (FGF) family is composed of 18 secreted signaling proteins consisting of canonical FGFs and endocrine FGFs that activate four receptor tyrosine kinases (FGFRs 1–4) and four intracellular proteins (intracellular FGFs or iFGFs) that primarily function to regulate the activity of voltage‐gated sodium channels and other molecules. The canonical FGFs, endocrine FGFs, and iFGFs have been reviewed extensively by us and others. In this review, we briefly summarize past reviews and then focus on new developments in the FGF field since our last review in 2015. Some of the highlights in the past 6 years include the use of optogenetic tools, viral vectors, and inducible transgenes to experimentally modulate FGF signaling, the clinical use of small molecule FGFR inhibitors, an expanded understanding of endocrine FGF signaling, functions for FGF signaling in stem cell pluripotency and differentiation, roles for FGF signaling in tissue homeostasis and regeneration, a continuing elaboration of mechanisms of FGF signaling in development, and an expanding appreciation of roles for FGF signaling in neuropsychiatric diseases. This article is categorized under: Cardiovascular Diseases > Molecular and Cellular Physiology Neurological Diseases > Molecular and Cellular Physiology Congenital Diseases > Stem Cells and Development Cancer > Stem Cells and Development
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
- Kyoto University Graduate School of Pharmaceutical Sciences, Sakyo, Kyoto, Japan.
ORCID-Profile: David M Ornitz
Förderung
- NICHD NIH HHS
- NIH HHS
- NIAMS NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- Hope Center for Neurological Disorders
- Musculoskeletal Research Center, Washington University in St. Louis
- Institute of Clinical and Translational Sciences
Zitieren
APA
Ornitz, D. M., & Itoh, N. (2022). New developments in the biology of fibroblast growth factors. WIREs Mechanisms of Disease, 14(4). https://doi.org/10.1002/wsbm.1549
Vancouver
Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mechanisms of Disease. 2022;14(4). doi:10.1002/wsbm.1549
BibTeX
@article{Ornitz2022,
author = {Ornitz, David M and Itoh, Nobuyuki},
title = {New developments in the biology of fibroblast growth factors},
journal = {WIREs Mechanisms of Disease},
year = {2022},
volume = {14},
number = {4},
doi = {10.1002/wsbm.1549}
}
EUVIMED